APA (7th ed.) Citation

Donahue, R. N., Schlom, J., Gulley, J. L., Palena, C., Hamilton, D. H., Iida, M., . . . Le, L. H. Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific T cells and promotes tumor control. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Donahue, Renee N., Jeffrey Schlom, James L. Gulley, Claudia Palena, Duane H. Hamilton, Masafumi Iida, Maria del Mar Maldonado, Maria Gracia-Hernandez, and Loc Huu Le. Combination of a Therapeutic Cancer Vaccine Targeting the Endogenous Retroviral Envelope Protein ERVMER34-1 with Immune-oncology Agents Facilitates Expansion of Neoepitope-specific T Cells and Promotes Tumor Control. BMJ Publishing Group.

MLA (9th ed.) Citation

Donahue, Renee N., et al. Combination of a Therapeutic Cancer Vaccine Targeting the Endogenous Retroviral Envelope Protein ERVMER34-1 with Immune-oncology Agents Facilitates Expansion of Neoepitope-specific T Cells and Promotes Tumor Control. BMJ Publishing Group.